TD Cowen maintains Buy on Medtronic, lowers target to $100
TD Cowen analyst Joshua Jennings maintained a Buy rating on Medtronic but lowered the price target to $100 from $119.

*this image is generated using AI for illustrative purposes only.
TD Cowen analyst Joshua Jennings has maintained a Buy rating on Medtronic while lowering the price target to $100 from $119. The adjustment reflects a revised valuation outlook for the company's stock.
Rating and Price Target Details
The analyst's decision to keep the Buy rating suggests continued confidence in Medtronic's performance despite the reduction in the price objective. The new target of $100 is down by $19 from the previous estimate of $119.
| Metric | Value |
|---|---|
| Rating | Buy |
| Previous Price Target | $119 |
| New Price Target | $100 |
What specific factors led TD Cowen to revise Medtronic's valuation outlook?
How might this price target reduction influence investor sentiment towards Medtronic in the short term?
What upcoming catalysts could help Medtronic reach the new $100 price target?


























